•
Jan 31, 2014

Summit Therapeutics Q4 2013 Earnings Report

Total Revenue
$760K
Previous year: $760K
+0.0%
EPS
-$0.272
Previous year: -$0.0889
+206.3%
Gross Profit
$461K
Previous year: $305K
+51.4%

Summit Therapeutics

Summit Therapeutics